新型急诊脓毒症快速诊断工具的验证
这项前瞻性队列研究在路易斯安那、密苏里、北卡罗来纳和华盛顿的5个急诊科纳入599例成人患者(最终分析572例),这些患者有感染征象(4项全身炎症反应综合征标准中2项,其中1项必须为体温或白细胞计数)或怀疑感染(医生开具培养)。所有患者均用乙二胺四乙酸抗凝全血进行IntelliSep检测,随后由盲法医师小组按脓毒症-3标准回顾性判定脓毒症。结果显示,ISI结果分为3个判读带,中位周转时间7.2分钟;脓毒症总发生率为26.6%(572例中152例),1带、2带、3带的脓毒症患病率分别为11.1%(95%CI 7.5-15.7%)、28.1%(95%CI 21.3-35.8%)和49.4%(95%CI 41.4-57.4%);1带的阳性百分比一致性为81.6%,3带的阴性百分比一致性为80.7%,受试者工作特征曲线下面积为0.74;与1带相比,3带与不良临床结局(包括死亡)和资源利用相关。作者认为,在急诊疑似感染患者中,ISI判读带升高与脓毒症概率增加相关。
要点
- 在572例急诊疑似感染成人中,ISI 1带脓毒症患病率11.1%(95%CI 7.5-15.7%),2带28.1%(95%CI 21.3-35.8%),3带49.4%(95%CI 41.4-57.4%)。
- ISI中位周转时间为7.2分钟,结果以0.1-10.0的指数分入3个判读带(1带低风险至3带高风险)。
- ISI判别脓毒症的受试者工作特征曲线下面积为0.74;1带阳性百分比一致性81.6%,3带阴性百分比一致性80.7%。
- 与1带相比,3带与不良临床结局(包括死亡)及资源利用相关。
- 脓毒症由盲法医师小组按脓毒症-3标准回顾性判定,总发生率26.6%(152/572)。
适用人群与场景
- 急诊成人患者,具备感染征象(4项全身炎症反应综合征标准中2项,其中1项必须为体温或白细胞计数)或怀疑感染(医生开具培养)。
- 研究在路易斯安那、密苏里、北卡罗来纳和华盛顿的5个急诊科进行。
诊断标准与关键阈值
- 脓毒症判定标准为脓毒症-3标准,由盲法医师小组回顾性判定。
- IntelliSep检测结果以IntelliSep指数(ISI)报告,范围0.1-10.0,分为3个判读带:1带(低风险)至3带(高风险)。
研究设计与关键结果
- 研究类型为前瞻性队列研究,共纳入599例患者,最终分析572例。
- ISI中位周转时间为7.2分钟;ISI结果为1带252例(44.1%)、2带160例(28.0%)、3带160例(28.0%)。
- 脓毒症总发生率为26.6%(152/572);1带脓毒症患病率11.1%(95%CI 7.5-15.7%),2带28.1%(95%CI 21.3-35.8%),3带49.4%(95%CI 41.4-57.4%)。
- 1带阳性百分比一致性为81.6%,3带阴性百分比一致性为80.7%,受试者工作特征曲线下面积为0.74。
- 与1带相比,3带与不良临床结局(包括死亡)及资源利用相关。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急诊疑似感染成人,ISI判读带升高与脓毒症概率增加相关,可辅助风险分层。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the in vitro IntelliSep test, a microfluidic assay that quantifies the state of immune activation by evaluating the biophysical properties of leukocytes, as a rapid diagnostic for sepsis.
DESIGN: Prospective cohort study.
SETTING: Five emergency departments (EDs) in Louisiana, Missouri, North Carolina, and Washington.
PATIENTS: Adult patients presenting to the ED with signs (two of four Systemic Inflammatory Response Syndrome criteria, where one must be temperature or WBC count) or suspicion (provider-ordered culture) of infection.
INTERVENTIONS: All patients underwent testing with the IntelliSep using ethylene diamine tetraacetic acid-anticoagulated whole blood followed by retrospective adjudication for sepsis by sepsis-3 criteria by a blinded panel of physicians.
MEASUREMENTS AND MAIN RESULTS: Of 599 patients enrolled, 572 patients were included in the final analysis. The result of the IntelliSep test is reported as the IntelliSep Index (ISI), ranging from 0.1 to 10.0, divided into three interpretation bands for the risk of sepsis: band 1 (low) to band 3 (high). The median turnaround time for ISI results was 7.2 minutes. The ISI resulted band 1 in 252 (44.1%), band 2 in 160 (28.0%), and band 3 in 160 (28.0%). Sepsis occurred in 26.6% (152 of 572 patients). Sepsis prevalence was 11.1% (95% CI, 7.5-15.7%) in band 1, 28.1% (95% CI, 21.3-35.8%) in band 2, and 49.4% (95% CI, 41.4-57.4%) in band 3. The Positive Percent Agreement of band 1 was 81.6% and the Negative Percent Agreement of band 3 was 80.7%, with an area under the receiver operating characteristic curve of 0.74. Compared with band 1, band 3 correlated with adverse clinical outcomes, including mortality, and resource utilization.
CONCLUSIONS: Increasing ISI interpretation band is associated with increasing probability of sepsis in patients presenting to the ED with suspected infection.
参考来源
- O'Neal HR, Sheybani R, Janz DR, et al. Validation of a Novel, Rapid Sepsis Diagnostic for Emergency Department Use. Crit Care Explor. 2024. PMID: 38333076. doi:10.1097/CCE.0000000000001026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。